We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-15.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.72B
AUM Growth
-$127M
Cap. Flow
+$291M
Cap. Flow %
16.93%
Top 10 Hldgs %
29.42%
Holding
147
New
37
Increased
70
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
TERP
TerraForm Power, Inc
TERP
+$33.5M
2
PANW icon
Palo Alto Networks
PANW
+$23.1M
3
SUNE
SUNEDISON, INC COM
SUNE
+$22.5M
4
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
+$17.8M
5
SPWR
SunPower Corporation Common Stock
SPWR
+$15.8M

Top Sells

Rank Stock Value
1
MNDT
Mandiant, Inc. Common Stock
MNDT
+$40.5M
2
TRN icon
Trinity Industries
TRN
+$24.1M
3
NRG icon
NRG Energy
NRG
+$19.6M
4
TEX icon
Terex
TEX
+$13M
5
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$4.26M

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 24.49%
3 Consumer Discretionary 14.42%
4 Industrials 7.04%
5 Real Estate 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
51
Sarepta Therapeutics
SRPT
$1.64B
$10.5M 0.61%
326,400
+67,300
+26% +$2.28M
RARE icon
52
Ultragenyx Pharmaceutical
RARE
$2.56B
$10.2M 0.59%
105,500
+21,400
+25% +$2.45M
VCYT icon
53
Veracyte
VCYT
$4.77B
$9.93M 0.58%
2,118,068
+66,570
+3% +$634K
NBIX icon
54
Neurocrine Biosciences
NBIX
$18.7B
$9.79M 0.57%
246,100
+94,700
+63% +$4.58M
LGND icon
55
Ligand Pharmaceuticals
LGND
$5.94B
$9.72M 0.56%
181,941
– –
AYR
56
DELISTED
Aircastle Ltd
AYR
$8.83M 0.51%
428,600
– –
DBVT
57
DBV Technologies
DBVT
$817M
$8.6M 0.5%
24,150
+11,310
+88% +$4.45M
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$11.7B
$8.47M 0.49%
80,400
+28,600
+55% +$3.82M
KITE
59
DELISTED
Kite Pharma, Inc.
KITE
$7.79M 0.45%
+140,000
New +$8.81M
ATHN
60
DELISTED
Athenahealth, Inc.
ATHN
$7.73M 0.45%
58,000
+41,700
+256% +$5.44M
CGNX icon
61
Cognex
CGNX
$10.4B
$7.05M 0.41%
410,000
– –
DVAX
62
DELISTED
Dynavax Technologies
DVAX
$6.89M 0.4%
280,700
+86,200
+44% +$2.44M
SGEN
63
DELISTED
Seagen Inc. Common Stock
SGEN
$6.79M 0.39%
176,200
+48,100
+38% +$2.17M
TSRO
64
DELISTED
TESARO, Inc.
TSRO
$6.74M 0.39%
168,000
+52,600
+46% +$2.87M
STML
65
DELISTED
Stemline Therapeutics, Inc.
STML
$6.49M 0.38%
735,000
+30,750
+4% +$323K
GWPH
66
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.28M 0.36%
68,700
+32,600
+90% +$3.62M
ININ
67
DELISTED
Interactive Intelligence Group, inc.
ININ
$6.25M 0.36%
210,200
-12,000
-5% -$458K
CERN
68
DELISTED
Cerner Corp
CERN
$6.09M 0.35%
101,600
+36,300
+56% +$2.37M
LOXO
69
DELISTED
Loxo Oncology, Inc
LOXO
$5.93M 0.34%
339,200
+95,500
+39% +$1.87M
ALNY icon
70
Alnylam Pharmaceuticals
ALNY
$27.4B
$5.68M 0.33%
70,700
+25,200
+55% +$2.8M
PWR icon
71
Quanta Services
PWR
$98.7B
$5.64M 0.33%
232,800
– –
NTUS
72
DELISTED
Natus Medical Inc
NTUS
$5.37M 0.31%
136,000
+61,000
+81% +$2.59M
SAGE
73
DELISTED
Sage Therapeutics
SAGE
$5.04M 0.29%
119,200
+79,000
+197% +$4.87M
RGEN icon
74
Repligen
RGEN
$7.03B
$4.97M 0.29%
178,400
+79,000
+79% +$2.85M
SUPN icon
75
Supernus Pharmaceuticals
SUPN
$2.65B
$4.89M 0.28%
348,600
+62,000
+22% +$1.15M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Eventide Asset Management held 147 positions worth $1.72B, down 6.9% from $1.85B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eventide Asset Management deployed $291M of net new capital in Q3 2015, opening 37 new positions and adding to 70 existing holdings. Its largest new stake was TerraForm Power, Inc: 1,249,550 shares worth $17.8M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Tetraphase Pharmaceuticals, Inc., an estimated $4.26M trimmed.

  • Eventide Asset Management's largest Q3 2015 buy was TerraForm Power, Inc: 1,249,550 shares worth $17.8M.
  • Eventide Asset Management added most to Palo Alto Networks in Q3 2015, an estimated $23.1M increase.
  • Eventide Asset Management's biggest Q3 2015 reduction was Tetraphase Pharmaceuticals, Inc., cutting an estimated $4.26M.
  • Eventide Asset Management fully exited Mandiant, Inc. Common Stock in Q3 2015, selling an estimated $40.5M.
  • Eventide Asset Management's ten largest holdings make up 29% of its $1.72B portfolio in Q3 2015.
  • Eventide Asset Management opened 37 new positions and closed 12 in Q3 2015.
  • Eventide Asset Management's portfolio value fell 6.9% quarter-over-quarter to $1.72B.

Based on Eventide Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.